Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Somi Health vs YourHealthRx

Somi Health
Graded #141

Lower grade

vs+0.8999999999999915
YourHealthRx
Graded #119

Higher grade

The verdict

YourHealthRx takes it — 69.6/100 to 68.7/100, but only just.

YourHealthRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform available in all 50 states and DC via a multi-state (IMLC) clinician network. Somi Health is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueSomi Health +13
66
53
Dose & formulationEven
75
75
Clinical oversightYourHealthRx +5
82
87
Labs & monitoringYourHealthRx +14
53
67
FulfillmentYourHealthRx +18
76
94
Contract termsSomi Health +14
47
33
Somi Health · left barYourHealthRx · right bar

The numbers

MetricSomi HealthYourHealthRx
WeighScore68.7/10069.6/100
GradeCC
Scorecard rank#141#119
Semaglutide$135/mo (starting dose, compounded)$170/mo (compounded)
Tirzepatide$165/mo (starting dose, compounded)$210/mo (compounded)
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Somi Health

Graded #141 · C

Strengths

  • Among the lowest compounded prices: semaglutide $135/mo, tirzepatide $165/mo (3-month plan)
  • Oral semaglutide tablet option for those who want no injections
  • One price at any dose, with the medical visit and shipping included
  • LegitScript Approved seal displayed; partnered with 503A pharmacies
  • Free 2-5 day shipping; no insurance required

Where it loses points

  • Compounded only - no brand-name Wegovy, Zepbound, Ozempic or Mounjaro
  • Homepage advertises a 100% money-back guarantee but Terms state all sales are final, no refunds on medication
  • Partner pharmacies are not individually named (material transparency gap)
  • No single prescribing medical group named; only affiliated professional entities
  • State availability not published; confirmed only during intake
YourHealthRx

Graded #119 · C

Strengths

  • Available in all 50 states and DC through a multi-state (IMLC) licensed clinician network
  • Compounded semaglutide and tirzepatide in two formats - weekly injectable (with B12) or daily oral dissolving tablet
  • Flat subscription price that doesn't change as your dose increases (no titration penalty)
  • Science-forward, clinician-led, with built-in follow-up, lab testing, and a broad peptide and longevity catalog (BPC-157, TB-500, sermorelin, NAD+)
  • Transparent, education-first positioning with published medical disclaimer, privacy, and terms

Where it loses points

  • Eligibility and prescribing run through partner clinical workflows - YourHealthRx is the platform, not the prescriber or pharmacy
  • Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
  • The compounding pharmacy partner is not named ('transparent sourcing' claimed but no pharmacy disclosed)
  • Headline prices include a first-month intro rate; ongoing monthly cost is higher (semaglutide ~$170, tirzepatide ~$210)
  • No LegitScript certification displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard